You searched for Parkinson's - Page 5 of 19

treefrog therapeutics cell therapy parkinsons disease

News and Trends 13 May 2019

Cell Encapsulation Biotech Raises €7M to Target Cell Therapy Bottlenecks

…the Series A money will help Treefrog to automate its stem cell production process by 2021. The round will also fund the development of a stem cell therapy for Parkinson’s…

May 13, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 13 Feb 2017

Biotech from the Bermuda Islands Brings Good News for Dementia Patients

…Parkinson’s disease dementia (PDD). Based on these positive preliminary results, the biotech is getting ready to recruit more patients and prepare for Phase III, which is expected to start in…

February 13, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 17 Sep 2024

Estonia: Seven biotech companies to reckon with

…RNA modifications to address these diseases. The company’s lead drug candidate, CHMA1004, is currently in the preclinical stage and is being developed to treat Parkinson’s disease, depression, anxiety, and post-traumatic…

September 17, 2024 - 7 minutesmins - By Jules Adam

Theranexus IPO CNS Narcolepsy Parkinsons Alzheimers

News and Trends 30 Oct 2017

French Biotech Closes €19M IPO to Treat Narcolepsy and Alzheimer’s

Theranexus debuts on Euronext Paris raising €19.6M that will support the development of its pipeline of CNS drugs for narcolepsy, Parkinson’s, Alzheimer’s and neuropathic pain. Theranexus, based in Lyon, starts…

October 30, 2017 - 4 minutesmins - By Clara Rodríguez Fernández

In Depth 31 Jan 2017

Biologicals on the Brain: Biotech in Neurodegenerative Disease

…Phase II trials and AFFiRiS, a Vienna-based biotech that currently has a Parkinson’s vaccine in a Phase 1b trial. “Our therapeutic is aimed at teaching the body to produce the…

January 31, 2017 - 7 minutesmins - By Diana Kwon

geneva biotech serono university of geneva

Best in Biotech 30 May 2017

In Geneva, the Capital of Peace, 10 Biotechs Are Putting up a Fight

…Swiss Exchange, works in a mostly virtual biotech model and is carrying on clinical programs on Parkinson’s Disease and epilepsy with some high-profile partnerships, including Janssen and the Michael J….

May 30, 2017 - 7 minutesmins - By Denise Neves Gameiro

alchemyrefiner alchemymagic 1 37c41ba7 555f 4f93 ad44 39b31d752775 0

Podcast 15 Mar 2024

Reformulating psychedelics for neurodegenerative diseases

…are conditions where the trip may be useful, conditions that are based on life trauma, such as PTSD,” Clark explained. Idazoxan’s journey from Parkinson’s to schizophrenia Idazoxan, which Terran Biosciences…

March 15, 2024 - 8 minutesmins - By Jim Cornall

Startup Scout 13 Oct 2017

This French Biotech is Taking On CNS Diseases of the Young and the Elderly

This week we’re in Castres in the South of France to visit Neurolixis. This biotech is taking on diseases of the CNS, such as Parkinson’s, depression and schizophrenia. Mission: Neurolixis…

October 13, 2017 - 2 minutesmins - By Alex Dale

News and Trends 11 Oct 2016

World Mental Health Day: How is Biotech Helping the Cause?

…Alzheimer’s, while Parkinson’s affects 6.3 million people. Current treatments deal with symptoms but cannot stop the progression of the disease. We interviewed the CSO of the Dementia Discovery Fund earlier…

October 11, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

BenevolentAI Artificial Intelligence Fundraising

News and Trends 19 Apr 2018

Major $115M Fundraising Fuels AI Drug Development

…diseases such as motor neuron disease and Parkinson’s that have been difficult to understand and treat up until now. Specifically, the technology can identify the molecular signs of a disease…

April 19, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 20 Dec 2022

Watch: IRLAB CEO Richard Godfrey

IRLAB discovers and develops novel treatments of Parkinson’s disease and other CNS disorders. The company’s most advanced drug candidates, mesdopetam (IRL790) and pirepemat (IRL752), are in phase IIb and are…

December 20, 2022 - 1 minutemin - By Jim Cornall

News and Trends 11 Jul 2023

NodThera first to show reduction in neuroinflammation with inflammasome inhibitor

…NodThera, said: “Taken together, these initial findings represent the first unambiguous demonstration of modulation of neuroinflammation in a human population with an NLRP3 inflammasome inhibitor. In designing our Parkinson’s disease…

July 11, 2023 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Parkinson's

Cell Encapsulation Biotech Raises €7M to Target Cell Therapy Bottlenecks

Biotech from the Bermuda Islands Brings Good News for Dementia Patients

Estonia: Seven biotech companies to reckon with

French Biotech Closes €19M IPO to Treat Narcolepsy and Alzheimer’s

Biologicals on the Brain: Biotech in Neurodegenerative Disease

In Geneva, the Capital of Peace, 10 Biotechs Are Putting up a Fight

Reformulating psychedelics for neurodegenerative diseases

This French Biotech is Taking On CNS Diseases of the Young and the Elderly

World Mental Health Day: How is Biotech Helping the Cause?

Major $115M Fundraising Fuels AI Drug Development

Watch: IRLAB CEO Richard Godfrey

NodThera first to show reduction in neuroinflammation with inflammasome inhibitor

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!